FINWIRES · TerminalLIVE
FINWIRES

Constellium Likely to See Higher for Longer Used Beverage Can Spreads, UBS Says

By

Constellium (CSTM) could see sustainably higher used beverage can spreads in the next two to three years due to Section 232 tariffs, UBS Securities said in a note Monday as it initiated coverage of the stock.

Analysts said they expect some moderation in UBC spreads due to incoming new and disrupted can sheet capacity, which presents a headwind for Constellium. This can be partially offset by growth in can sheet volume and the rebounding demand in higher margin aerospace and automotive aluminum products, the brokerage said.

The company provides investors with direct exposure to scrap spreads through its Packaging & Auto Rolled Product segment, which produces over 75% of volume from can sheet body stock, according to the note.

The market is overlooking sustainably higher used beverage can spreads, with the consensus estimate at about 52% for 2027, compared with UBS's estimate of 55%, the note said.

UBS has a buy rating on Constellium, and a price target of $38.

Shares of Constellium were up more than 7% in Tuesday trading.

Price: $33.10, Change: $+2.26, Percent Change: +7.33%

Related Articles

Wire

IAC Q1 Loss Narrows, Revenue Falls; Shares Drop After Hours

IAC (IAC) reported a Q1 loss late Monday of $0.94 per diluted share, narrowing from the loss of $2.64 a year earlier.Analysts polled by FactSet expected a loss of $0.37.Revenue in the three months ended March 31 fell to $422.9 million from $481.7 million a year earlier.Analysts surveyed by FactSet expected $520.3 million.IAC shares fell 8.6% in after-hours trading.

$IAC
Wire

Vornado Realty Trust Q1 Non-GAAP FFO, Revenue Fall; Shares Drop After Hours

Vornado Realty Trust (VNO) reported Q1 non-GAAP funds from operations late Monday of $0.52 per diluted share, down from $0.63 a year earlier.Analysts polled by FactSet expected $0.51.Revenue in the three months ended March 31 fell to $459.1 million from $461.6 million a year earlier.Analysts surveyed by FactSet expected $431.7 million.Vornado shares fell 3% in after-hours trading.

$VNO
Wire

GeneDx Q1 Swings to Adjusted Loss, Revenue Rises; 2026 Revenue Guidance Lowered; Shares Fall

GeneDx (WGS) reported Monday Q1 adjusted loss of $0.28 per diluted share, swinging from an adjusted earnings of $0.31 a year earlier.Analysts polled by FactSet expected loss of $0.02.Revenue for the quarter ended March 31 was $102.3 million, up from $87.1 million a year earlier.Analysts surveyed by FactSet expected $112.5 million.For Q2, the company expects revenue of $110 million to $112 million. Analysts expect $130.3 million.The company now expects 2026 revenue of $475 million to $490 million, down from $540 million to $555 million expected earlier. Analysts expect $550.0 million.Shares of the company were down over 45% during after-hours activity.

$WGS